, Tracking Stock Market Picks
Enter Symbol:
Oncolytics Biotech, Inc. (ONCY) [hlAlert]

down 56.91 %

Oncolytics Biotech, Inc. (ONCY) rated Buy by Merriman Curhan Ford

Posted on: Thursday,  Oct 16, 2008  8:25 AM ET by Merriman Curhan Ford

Merriman Curhan Ford rated Buy Oncolytics Biotech, Inc. (NASDAQ: ONCY) on 10/16/2008, when the stock price was $1.23.
Since then, Oncolytics Biotech, Inc. has lost 56.91% as of 11/04/2015's recent price of $0.53.
If you would have followed this Merriman Curhan Ford's recommendation on ONCY, you would have lost 56.91% of your investment in 2575 days.

Oncolytics Biotech, Inc. focuses on the discovery and development of pharmaceutical products for the treatment of a wide variety of human and companion pet cancers. The Company was formed to explore the oncolytic capability of the reovirus, a virus that preferentially replicates in cells with an activated Ras pathway, one of the most common family of genetic defects leading to cancer.

We occupy a unique niche among our investment banking peers: we offer our clients both traditional sell-side equity research and primary market research, and we focus on high-potential sectors such as CleanTech, Consumer/Internet/Media, Health Care and Tech/Telecom. Our institutional and corporate clients get the best of both worlds: expertise from our analysts and access to experts through our Panel Intelligence platform.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/16/2008 8:25 AM Buy
as of 12/24/2008
1 Week up  23.12 %
1 Month up  38.16 %
3 Months up  49.58 %
1 YTD up  49.58 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy